<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477128521</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111657.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19971101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1023/A:1012182419037</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1023/A:1012182419037</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Understanding How Elderly Patients Process Drug Information: A Test of a Theory of Information Processing</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Thomas Christensen, Frank Ascione, Richard Bagozzi]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Purpose. The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to 'direct-to-consumer' advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional aspects of consumer drug advertising predicted by the ELM could be demonstrated on elderly consumers' product attitudes and perceptions of risk. Methods. Subject reaction to a fictitious drug advertisement was assessed using a 2 × 2 × 2 factorial design based on the theoretical concepts of the ELM. The advertisement message varied in the expertise of the product endorser, the expected involvement or interest level of the study subject, and the content of the advertisement message. Results. Analysis of variance revealed a three-way interaction effect between involvement, argument quality, and source credibility on subjects' attitudes toward the product [F(l, 123) = 4.77, p = 0.03] and perceptions of risk [F(l, 118) = 3.22, p = 0.08]. The information content of the ads had an impact on subject's attitudes under the low involvement/low credibility condition but not the low involvement/ high credibility condition. Under high involvement conditions, the information content of the ad impacted attitudes under both the high and low credibility conditions. Conclusions. It appears that the ELM may be a useful model for determining when elderly individuals are more likely to be influenced by the information content or the promotional aspects of consumer advertisements for prescription drugs.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Plenum Publishing Corporation, 1997</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">advertising</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">prescription drugs</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">consumer behavior</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">elaboration likelihood model</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">risk perception</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Christensen</subfield>
   <subfield code="D">Thomas</subfield>
   <subfield code="u">Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ascione</subfield>
   <subfield code="D">Frank</subfield>
   <subfield code="u">College of Pharmacy, University of Michigan, Ann Arbor, Michigan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bagozzi</subfield>
   <subfield code="D">Richard</subfield>
   <subfield code="u">Michigan Business School, University of Michigan, Ann Arbor, Michigan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Pharmaceutical Research</subfield>
   <subfield code="d">Kluwer Academic Publishers-Plenum Publishers</subfield>
   <subfield code="g">14/11(1997-11-01), 1589-1596</subfield>
   <subfield code="x">0724-8741</subfield>
   <subfield code="q">14:11&lt;1589</subfield>
   <subfield code="1">1997</subfield>
   <subfield code="2">14</subfield>
   <subfield code="o">11095</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1023/A:1012182419037</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1023/A:1012182419037</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Christensen</subfield>
   <subfield code="D">Thomas</subfield>
   <subfield code="u">Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ascione</subfield>
   <subfield code="D">Frank</subfield>
   <subfield code="u">College of Pharmacy, University of Michigan, Ann Arbor, Michigan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bagozzi</subfield>
   <subfield code="D">Richard</subfield>
   <subfield code="u">Michigan Business School, University of Michigan, Ann Arbor, Michigan</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Pharmaceutical Research</subfield>
   <subfield code="d">Kluwer Academic Publishers-Plenum Publishers</subfield>
   <subfield code="g">14/11(1997-11-01), 1589-1596</subfield>
   <subfield code="x">0724-8741</subfield>
   <subfield code="q">14:11&lt;1589</subfield>
   <subfield code="1">1997</subfield>
   <subfield code="2">14</subfield>
   <subfield code="o">11095</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
